Does Blue Cross and Blue Shield of Vermont cover Zepbound or Wegovy?
Last updated
No weight-loss GLP-1s since January 1, 2026; diabetes and Wegovy for heart disease stay covered.
If it is not covered: the lowest cash prices now

Without insurance: compounded tirzepatide on a monthly plan, not FDA-approved
$69/mo + $199/yr membership · about $86 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

Without insurance: compounded semaglutide on a monthly plan, not FDA-approved
$59/mo + $199/yr membership · about $76 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before
No weight-loss GLP-1s since January 1, 2026; diabetes and Wegovy for heart disease stay covered. Blue Cross and Blue Shield of Vermont stopped covering GLP-1s approved for weight loss, Wegovy, Zepbound and Saxenda among them, on January 1, 2026; members who keep taking them pay the full cost. In its words: "Beginning January 1, 2026, Blue Cross and Blue Shield of Vermont will no longer cover prescription drugs containing Glucagon-Like Peptide-1 (GLP-1) receptor agonists that are FDA-approved for weight loss, including Wegovy®, Zepbound® and Saxenda®. This will be a benefit exclusion. After this date, members who continue to use these medications will be responsible for the full cost." (Blue Cross VT, Frequently Asked Questions: 2026 Coverage Changes for GLP-1 Drugs FDA-Approved for Weight Loss, bluecrossvt.org/documents/glp-1-faqs, read Nov 19, 2026).
Blue Cross and Blue Shield of Vermont, Zepbound and Wegovy: common questions
Does Blue Cross and Blue Shield of Vermont cover Zepbound for weight loss?
No weight-loss GLP-1s since January 1, 2026; diabetes and Wegovy for heart disease stay covered. Blue Cross and Blue Shield of Vermont stopped covering GLP-1s approved for weight loss, Wegovy, Zepbound and Saxenda among them, on January 1, 2026; members who keep taking them pay the full cost. In its words: "Beginning January 1, 2026, Blue Cross and Blue Shield of Vermont will no longer cover prescription drugs containing Glucagon-Like Peptide-1 (GLP-1) receptor agonists that are FDA-approved for weight loss, including Wegovy®, Zepbound® and Saxenda®. This will be a benefit exclusion. After this date, members who continue to use these medications will be responsible for the full cost." (Blue Cross VT, Frequently Asked Questions: 2026 Coverage Changes for GLP-1 Drugs FDA-Approved for Weight Loss, bluecrossvt.org/documents/glp-1-faqs, read Nov 19, 2026). Zepbound not covered: the cash price at your dose
Does Blue Cross and Blue Shield of Vermont cover Wegovy for weight loss?
No weight-loss GLP-1s since January 1, 2026; diabetes and Wegovy for heart disease stay covered. Blue Cross and Blue Shield of Vermont stopped covering GLP-1s approved for weight loss, Wegovy, Zepbound and Saxenda among them, on January 1, 2026; members who keep taking them pay the full cost. In its words: "Beginning January 1, 2026, Blue Cross and Blue Shield of Vermont will no longer cover prescription drugs containing Glucagon-Like Peptide-1 (GLP-1) receptor agonists that are FDA-approved for weight loss, including Wegovy®, Zepbound® and Saxenda®. This will be a benefit exclusion. After this date, members who continue to use these medications will be responsible for the full cost." (Blue Cross VT, Frequently Asked Questions: 2026 Coverage Changes for GLP-1 Drugs FDA-Approved for Weight Loss, bluecrossvt.org/documents/glp-1-faqs, read Nov 19, 2026). Wegovy not covered: the cash price at your dose
Does Blue Cross and Blue Shield of Vermont cover Wegovy for heart disease?
Wegovy stays covered with prior approval for an adult with diagnosed cardiovascular disease and obesity, to reduce the risk of cardiovascular events. In its words: "You are an adult with diagnosed cardiovascular disease and obesity, and your provider prescribes Wegovy® to reduce your risk of certain cardiovascular events." (Blue Cross VT, Frequently Asked Questions: 2026 Coverage Changes for GLP-1 Drugs FDA-Approved for Weight Loss, bluecrossvt.org/documents/glp-1-faqs, read Nov 19, 2026).
Is Blue Cross and Blue Shield of Vermont dropping GLP-1 coverage for weight loss?
No weight-loss GLP-1s since January 1, 2026; diabetes and Wegovy for heart disease stay covered. Blue Cross and Blue Shield of Vermont stopped covering GLP-1s approved for weight loss, Wegovy, Zepbound and Saxenda among them, on January 1, 2026; members who keep taking them pay the full cost. In its words: "Beginning January 1, 2026, Blue Cross and Blue Shield of Vermont will no longer cover prescription drugs containing Glucagon-Like Peptide-1 (GLP-1) receptor agonists that are FDA-approved for weight loss, including Wegovy®, Zepbound® and Saxenda®. This will be a benefit exclusion. After this date, members who continue to use these medications will be responsible for the full cost." (Blue Cross VT, Frequently Asked Questions: 2026 Coverage Changes for GLP-1 Drugs FDA-Approved for Weight Loss, bluecrossvt.org/documents/glp-1-faqs, read Nov 19, 2026).
Why did Blue Cross and Blue Shield of Vermont change its GLP-1 coverage?
Blue Cross VT says it weighed how well the drugs work over the long term and what covering them does to members' premiums. In its words: "Blue Cross VT made this change after considering the long-term effectiveness and the impact on member premiums by continuing coverage for GLP-1 weight loss medications." (Blue Cross VT, Frequently Asked Questions: 2026 Coverage Changes for GLP-1 Drugs FDA-Approved for Weight Loss, bluecrossvt.org/documents/glp-1-faqs, read Nov 19, 2026).
What do Zepbound and Wegovy cost if Blue Cross and Blue Shield of Vermont does not cover them?
Zepbound costs $299/28 days at 2.5 mg and $449/28 days at 15 mg without insurance at Amazon Pharmacy and LillyDirect (Eli Lilly), checked Nov 19, 2026 on pharmacy.amazon.com and zepbound.lilly.com. At 15 mg, the terms: at Amazon Pharmacy, through Dec 31, 2026, with Lilly's self-pay card, whose terms on Lilly's Zepbound savings page say "Card expires and savings end on 12/31/2026" and require each refill within 45 days of the previous delivery, or Lilly's regular $699 applies; at LillyDirect (Eli Lilly), Self Pay Journey price with a refill within 45 days; otherwise $499 at 7.5 mg or $699 at 10 to 15 mg. Wegovy costs $199/28 days, through Dec 31, 2026 at 0.25 mg and $349/28 days at 2.4 mg without insurance at Amazon Pharmacy and NovoCare (Novo Nordisk), checked on pharmacy.amazon.com Nov 19, 2026 and on novocare.com Nov 11, 2026. Compounded, not FDA-approved: compounded tirzepatide from $69/mo + $199/yr membership at Collective (about $86 a month over a year with the membership) among sellers that serve Vermont; compounded semaglutide from $59/mo + $199/yr membership at Collective (about $76 a month over a year with the membership) among sellers that serve Vermont. Every GLP-1's cash price without insurance
Does Medicaid cover Zepbound or Wegovy?
It depends on the state: 10 state programs cover GLP-1s for weight loss, by KFF's January 2026 map and the states' own notices since. Every state's Medicaid answer
GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.